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Summary
A common characteristic of aging is defective regeneration of
skeletal muscle. The molecular pathways underlying age-related
decline in muscle regenerative potential remain elusive. micro-
RNAs are novel gene regulators controlling development and
homeostasis and the regeneration of most tissues, including
skeletal muscle. Here, we use satellite cells and primary
myoblasts from mice and humans and an in vitro regeneration
model, to show that disrupted expression of microRNA-143-3p
and its target gene, Igfbp5, plays an important role in muscle
regeneration in vitro. We identified miR-143 as a regulator of the
insulin growth factor-binding protein 5 (Igfbp5) in primary
myoblasts and show that the expression of miR-143 and its
target gene is disrupted in satellite cells from old mice. Moreover,
we show that downregulation of miR-143 during aging may act
as a compensatory mechanism aiming at improving myogenesis
efficiency; however, concomitant upregulation of miR-143 target
gene, Igfbp5, is associated with increased cell senescence, thus
affecting myogenesis. Our data demonstrate that dysregulation
of miR-143-3p:Igfbp5 interactions in satellite cells with age may
be responsible for age-related changes in satellite cell function.
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Introduction
Age-related loss of skeletal muscle mass and function results in frailty,
decline in strength and decrease in quality of life of older people. Age-
related changes in muscle are thought to depend on a number of
changes including mitochondrial production of reactive oxygen species
(Jackson & McArdle, 2011), changes in muscle niche (Carlson & Conboy,
2007) and intracellular changes, such as changes in gene expression
(Jejurikar et al., 2006). Regeneration of adult skeletal muscle is largely
dependent on satellite cell population (Morgan & Partridge, 2003). The
availability and functionality of satellite cells determine effective regen-
eration. Aging-related changes in satellite cell number and properties,
such as susceptibility to apoptosis and ability to proliferate, have been
shown in humans and rodents (Brack et al., 2007; Collins et al., 2007;
Verdijk et al., 2007). Moreover, the presence of senescent satellite cells
in old mice and humans characterized by increased expression p16INK4a
and decreased phosphorylation of the retinoblastoma (RB) protein was
shown (Sousa-Victor et al., 2014).
microRNAs (miRNAs, miRs) affect the mRNA and protein content of
the cell providing a rapid, high-throughput mechanism of post-
transcriptional response to changes within and outside the cell. miRNAs
are short, noncoding RNAs that regulate gene expression at the post-
transcriptional level. They are implicated in many biological processes,
including skeletal muscle homeostasis (Goljanek-Whysall et al., 2012b).
miRs guide RNA-induced silencing complex (RISC) to partially comple-
mentary sequences, usually contained within the 30UTR of target
mRNAs. miR interaction with its target(s) results in a translational block
and often degradation of the mRNA. Occasionally, miRs activate the
expression of their target. Muscle-specific miRs are crucial regulators of
skeletal muscle function (McCarthy & Esser, 2007; Goljanek-Whysall
et al., 2011, 2012a, 2014; Brown & Goljanek-Whysall, 2015). Satellite
cell-specific Dicer knockout in a mouse model resulted in mild myofibre
atrophy (Cheung et al., 2012). Although differential expression of miRs
in muscle has been described during aging (Drummond et al., 2008; Kim
et al., 2014), the relevance of these changes is not yet understood.
miR-143-3p (miR-143) has an established role in the function of
smooth muscle myoblasts and adipogenesis (Esau et al., 2004; Cordes
et al., 2009; Elia et al., 2009; Xin et al., 2009). miR-143-5p is highly
expressed in skeletal muscle tissue, and its expression is downregulated
during aging (Kim et al., 2014). A set of miR-143 predicted targets is
associated with insulin-like growth factor (IGF) signalling (Blumensatt
et al., 2014). The IGF signalling pathway plays a crucial role in the
maintenance of skeletal muscle homeostasis. IGF1 and IGF2 stimulate
myoblast proliferation and differentiation, and these actions are medi-
ated by the action of IGF1 receptor (IGF1R) (Duan et al., 2010). In
addition to IGF1 receptors, IGF-binding proteins (IGFBPs) are an
important part of IGF signalling. IGFBPs are a family of proteins that
bind IGF1 and IGF2 (Duan et al., 2010). IGFBPs not only regulate the
half-life of circulating IGF and modulate IGF activity in local tissues, but
also have IGF-independent functions (James et al., 1996; Cobb et al.,
2004; Salih et al., 2004). The role of IGFBP5 in muscle is not fully
understood; however, it has been shown to regulate myoblast prolifer-
ation, viability and differentiation, both via and independently of the IGF
signalling (James et al., 1996; Cobb et al., 2004; Ren et al., 2008).
For the first time, this study investigates the regulation of IGF
signalling-related factor – Igfbp5 – by miR-143 in satellite cells and the
role of miR-143:Igfbp5 interactions in myoblast viability, senescence and
myogenic differentiation potential. We hypothesize that age-related
downregulation of miR-143 expression and a concomitant upregulation
of its target gene, Igfbp5, in satellite cells may act as a compensatory
mechanism aimed to improve muscle regeneration during aging.
Results
miR-143 is downregulated in satellite cells with age
To investigate whether miR-143 may play a role during muscle
regeneration, miR-143 expression was analysed by qPCR during muscle
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regeneration (Fig. 1A). Following the injury of muscle of adult mice, the
expression of miR-143 was downregulated at days 7 and 14 postinjury
and returned to the basal levels 21 days after injury (Fig. 1A). The
expression of miR-143 in the muscle of old mice following injury was
downregulated at day 1 postinjury and remained low 21 days postinjury
(Fig. 1A). This suggests that miR-143 dysregulation of expression is
relevant in regenerating muscle of old mice. To identify biologically
relevant miR-143 targets, candidate targets predicted by TargetScan
Human (v 6.2) and with known functions in the muscle were selected for
further analysis. This led to the identification of biologically relevant
targets: Igf1r, Igfr2 and Igfbp5 – members of the IGF signalling (Fig. S3A).
The expression of Igfbp5 mRNA was initially decreased (day 1) and next
increased (from day 7) during the regeneration of muscle of adult mice
and increased throughout the regeneration of muscle of old mice
(Fig. 1B). The expression of Igf1r, but not Igf2r, during muscle regener-
ation also negatively correlated with the expression of miR-143 (Fig. S2D).
As satellite cells play a key role during muscle regeneration, satellite
cells from the muscle of adult and old mice were isolated by FACS
(Fig. S1). Human primary myoblasts and not satellite cells were isolated
due to the small size of the muscle sample. qPCR analysis demonstrated
decreased expression of miR-143 (Fig. 1C) and upregulated expression
of Igfbp5 (Fig. 1D) in the satellite cells from old mice and primary
myoblasts from older mice and humans. The expression of Igf1r, but not
Igf2r, was also upregulated in the myoblasts from old mice and humans,
but not in the satellite cells from old mice (Fig. S2C, S6E).
miR-143 expression and Igfbp5, but not Igf1r, expression were
inversely correlated in the satellite cells during aging (Fig. 1D, S6E),
suggesting that miR-143 may play a role in age-related defective muscle
regeneration through regulating the expression of Igfbp5.
miR-143 directly regulates the expression of Igfbp5
The 30UTR of Igfbp5 has one putative miR-143 binding site conserved
between humans and mouse (Fig. 2A). To validate Igfbp5 as physiolog-
ically relevant miR-143 target, we investigated the expression of Igfbp5
in primary mouse and human myoblasts following miR-143 overexpres-
sion or inhibition using miRNA mimic or anti-miR (AM143), respectively
(Fig. 2B, C). The efficiency of the transfections was validated in
myoblasts (Fig. S3B, C, D). The expression of Igfbp5 mRNA and protein
in mouse and human myoblasts was downregulated following the
overexpression of miR-143 and upregulated following the inhibition of
miR-143 function in primary myoblasts (Fig. 2B, C). To establish whether
miR-143 directly interacts with Igfbp5 30UTR, we generated a reporter
containing a fragment of Igfbp5 30UTR downstream of GFP reporter
(‘wild-type’, WT). ‘Mutant’ reporter contained mutated miR-143 binding
site. Myoblasts were co-transfected with miR-143 mimic or miR-24
mimic, not predicted to target Igfbp5. The GFP reporter containing WT
Igfbp5 30UTR was efficiently regulated by miR-143, but not by miR-24
(Fig. 2D, E). Mutation of the putative target site in the 30UTR rendered
the reporter insensitive to miR-143, indicating that interaction with the
target site is required for the response (Fig. 2D, E). To further
demonstrate the biological relevance of miR-143 targeting Igfbp5, we
analysed IGFBP5 expression in FACS-sorted satellite cells from the adult
and old mice (Fig. 2F, G). As anticipated, IGFBP5 protein expression was
inversely correlated with the expression of miR-143 in the satellite cells
from both adult and old mice.
miR-143 regulates myogenesis in an in vitro model of muscle
regeneration
To validate the role of miR-143:Igfbp5 interactions in a physiologically
relevant context, an in vitro model of muscle regeneration was used
(Fig. 3). The changes in expression levels of miR-143 and Igfbp5 following
transfections were physiologically relevant (5- to 10-fold; Fig. S3B, C). The
potential of satellite cells to form new myotubes (‘regenerate’) was
establishedbyquantifying the totalmyotubeareaand fusion index (Fig. 3).
Satellite cells from the adultmice formedmoremyotubes containingmore
nuclei as compared with the satellite cells from the old mice (Fig. 3). miR-
143 overexpression led to the formation of fewer myotubes (Fig. 3A, C)
containing less nuclei (Fig. 3A, B) compared with mock-transfected cells.
Conversely, miR-143 inhibition led to the formation of more myotubes
(Fig. 3A, C) containing more nuclei (Fig. 3A, B) compared with control.
Overexpression of IGFBP5 in the satellite cells from the oldmice resulted in
the formation of a higher number of myotubes and higher fusion index
(Fig. 3). Interestingly, upregulation of IGFBP5 expression rescued the
effect related tomiR-143 overexpression and silencing of Igfbp5 abolished
the effect of miR-143 inhibition – the myotubes formed were character-
ized by fusion index similar to the control sample (Fig. 3). These data
Fig. 1 Expression of miR-143 and Igfbp5
changes during aging and muscle
regeneration. (A) qPCR demonstrating
changes in miR-143 expression following
mouse muscle (TA, tibialis anterior) injury by
barium chloride in the adult and old mice;
day 0 – noninjured muscle; day 1/7/14/21 –
days postinjury. (B) qPCR showing changes
in Igfbp5 expression in TA muscle of the
adult and old mice following injury. (C)
qPCR showing the expression of miR-143 in
mouse satellite cells and human myoblasts
during aging. (D) qPCR showing increased
Igfbp5 expression in mouse satellite cells
and human primary myoblasts during
aging. Error bars show SEM, * – P < 0.05
(compared to adult or noninjured control,
respectively), + – P < 0.05 (compared to
adult); n = 3–4 biological replicates.
Expression relative to Rnu-6 (miR-143) or
b-2-microglobulin (Igfbp5) is shown.
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suggest that miR-143:Igfpb5 interactions play a biologically relevant role
during myogenesis in vitro.
miR-143 regulates myogenic differentiation in vitro
Efficient muscle regeneration depends on activation, proliferation and
viability of satellite cells, as well as their differentiation potential. miR-
143 gain- and loss-of-function approaches were used to establish the
role of miR-143 in myogenic differentiation in vitro. miR-143 overex-
pression in mouse and human myoblasts resulted in the formation of
fewer myotubes containing less nuclei, whereas the inhibition of miR-
143 led to the formation of more myotubes containing more nuclei, as
shown by total myotube area and fusion index (Fig. 4). Overexpression
of IGFBP5 in the myoblasts from the old mice resulted in the formation of
more myotubes with a significant change in fusion index (Fig. 4).
Silencing of IGFBP5 expression resulted in a decreased fusion efficiency
of myoblasts from the adult, but not old, mice. Co-transfection of miR-
143 with IGFBP5 overexpression vector or AM143 with siRNA against
Igfbp5 resulted in rescuing of the phenotype associated with miR-143
overexpression or inhibition, respectively (Fig. 4). Interestingly, the
effects of miR-143 or IGFBP5 expression manipulation were consistent
during terminal differentiation (Fig. S4). These data suggest that miR-
143:Igfbp5 interactions may play a role in regulating the efficiency of
myogenic differentiation, with miR-143, IGFBP5 and potentially other
miR-143 targets, controlling myoblasts fusion.
miR-143:Igfbp5 interactions regulate myoblast viability
Effective muscle regeneration depends on satellite cells viability. Human
and mouse myoblasts were seeded at low density and transfected with
miR-143 mimic or inhibitor, or Igfbp5 construct or siRNA. MTS assay was
used to quantify the number of viable cells (Fig. 5B). Transfection of miR-
143 had a dramatic effect on the number of viable myoblasts (Fig. 5B).
This was not associated with cell proliferation as shown by Ki67
immunostaining (Fig. S5). Increased levels of miR-143 resulted in
decreased cell number and increased myoblasts death as compared
with control; this was consistent between mouse and human myoblasts
(Fig. 5A, C, S5). Inhibition of miR-143, as well as IGFBP5 overexpression,
Fig. 2 miR-143 represses Igfbp5
expression in mouse and human primary
myoblasts. (A) Alignment of putative miR-
143 target site in the 30UTR of Igfbp5 gene;
human and mouse sequences are indicated;
conserved miR-143 putative target site is
indicated in grey; complementary
nucleotides are shown in grey, and miR-143
seed sequence is highlighted. (B, C)
Endogenous Igfbp5 protein and mRNA
expression is regulated by miR-143 in the
mouse and human myoblasts, as shown by
Western blot or qPCR, respectively. (D, E)
GFP-Igfbp5 30UTR sensor constructs
containing conserved mouse wild-type or
mutated miR-143 target site were
transfected into mouse myoblasts. Co-
transfection with miR-143 mimic (miR-143),
but not miR-24 mimic (not predicted to
target Igfbp5), led to the downregulation of
GFP protein expression compared to mock-
transfected control (Ctrl), as shown by
Western blot. Point mutations in the
microRNA target site (mutant) rendered the
sensor construct unresponsive. (F, G)
Western blot showing increased expression
of IGFBP5 protein in FACS-sorted satellite
cells from the old mice compared with the
satellite cells from the adult mice. qPCR
data show SEM; * – P < 0.05 (compared to
control); representative Western blots are
shown; n = 3.
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resulted in significantly increased viability of myoblasts from humans and
mice (Fig. 5A, B, C). Moreover, overexpression of IGFBP5 in cells
transfected with miR-143 mimic or silencing of Igfbp5 expression in
myoblasts transfected with AM143 rescued the phenotypes associated
with miR-143 overexpression or inhibition, respectively (Fig. 5).
Overall, these data suggest that miR-143:Igfbp5 interactions primarily
regulate the viability of mouse and human myoblasts controlling the
number of viable myoblasts available for differentiation.
miR-143:Igfbp5 interactions regulate myoblasts senescence
We have shown that IGFBP5 overexpression preserved the viability of
myoblasts (Fig. 5); however, it was moderately associated with more
efficient fusion into myotubes. Because more unfused myoblasts were
observed following the overexpression of IGFBP5, we investigated miR-
143:Igfbp5 regulation of cellular senescence. We stained transfected
myoblasts for senescence-associated-b-galactosidase (SA-b-gal; Fig. 6).
Inhibition of miR-143 or IGFBP5 overexpression in myoblasts from both
mice and human resulted in the detection of more senescent cells
(Fig. 6A, C). This was related with increased p16INK4a expression and
reduced phosphorylation of RB (Ser608) (Fig. 6B). miR-143 overexpres-
sion resulted in reduced p16INK4A protein expression and increased RB
phosphorylation (Fig. 6B–D). Moreover, silencing of p16 INK4A expression
in myoblasts transfected with miR-143 inhibitor or IGFBP5 overexpres-
sion vector largely prevented the increase in senescent cell number,
suggesting that miR-143:Igfbp5 interactions may regulate cell senes-
cence via regulating p16 expression (Fig. 6A–C). These data suggest that
decreased levels of miR-143 and increased levels of its target gene,
Igfbp5, protect the myoblasts from atrophy/apoptosis at the cost of their
senescence, affecting their myogenic potential.
miR-143 and Igfbp5 expression in primary myoblasts is
regulated by IL-6
Having established the role of miR-143:Igfbp5 interactions in myoblasts,
the factors leading to disrupted expression of miR-143 and Igfbp5 during
aging were investigated. Primary myoblasts were treated with IL-6, a
cytokine with suggested role in aging (Ershler et al., 1993). IL-6 treatment
of myoblasts resulted in decreased expression of miR-143 (Fig. 6D) and
increased expression of Igfbp5 (Fig. 6D) in the myoblast from humans
and mice compared with mock-treated controls. These data suggest that
changes in circulatory factors, such as IL-6, during aging may influence
skeletal muscle regeneration by regulating the expression of microRNAs
and their target gene(s) in satellite cells (Fig. 6E).
Discussion
The molecular mechanisms responsible for age-related decline in satellite
cell function and muscle regeneration remain elusive. Transcriptional
networks altered with aging have been well characterized (Giresi et al.,
2005); however, whether global changes in the expression of genes
related to muscle regeneration play a causative or compensatory role in
age-related defective muscle regeneration remains an unanswered
question.
miRs are predicted to regulate 2/3 of the human genome, and they
are therefore likely to play a major role during aging-related decline in
muscle regeneration. Changes in miRNA expression in muscle with age
have been described in rodents and humans (Drummond et al., 2008;
Kim et al., 2014); however, the functional relevance of this is not yet
understood.
miR-143 has been shown to regulate the expression of MyoD in
myoblasts (Chen et al., 2014). In other tissues, miR-143 impairs glucose
metabolism through the induction of insulin resistance (Jordan et al.,
2011), regulates the contractility and maintenance of smooth muscle
myoblasts (Elia et al., 2009) and controls vascular remodelling following
injury (Xin et al., 2009) and intestinal epithelial regeneration (Chivukula
et al., 2014).
Our results show that miR-143 expression is decreased in the satellite
cells with age and this is associated with the increased expression of its
target, Igfbp5, at both transcript and protein levels.
We show that miR-143 directly regulates Igfbp5 expression in mouse
and human myoblasts (Fig. 2) and that miR-143:Igfbp5 interactions are
disrupted in the satellite cells and during muscle regeneration in vitro
with age (Fig. 1). For the first time, we demonstrate that miR-143
regulates myogenesis in vitro (Fig. 3). Moreover, we show that miR-143:
Igfbp5 regulates viability and senescence of human and mouse
myoblasts (Figs 4 and 5) and therefore affects their myogenic potential
(Figs 3–6). Importantly, our data show that miR-143:Igfbp5 interactions
are conserved between mouse and humans.
Our data reveal that IGFBP5 overexpression resulted in more
pronounced phenotype in the myoblasts from the old mice (Figs 4–6).
We propose that this may be a result of age-related intracellular
changes, such as differential expression of IGFBP5-responsive factors, for
example IGF receptors, specifically Igf1r, expression of which is upreg-
ulated in the myoblasts from the old mice and humans (Fig. S2C). We
have validated Igf1r as miR-143 target (Fig. S6) and propose that Igf1r is
an important mediator of miR-143 regulation of myogenesis, consistent
with previously described role of Igf1r (Duan et al., 2010).
Fig. 3 miR-143 negatively regulates the regeneration of muscle in vitro via
repressing Igfbp5 expression. (A) Satellite cells migrating out of isolated single
myofibres were transfected with miR-143 mimic (miR-143), anti-miR (AM143) and/
or Igfbp5 overexpression construct or siRNA against Igfbp5, as indicated; new
myotube formation was established by myosin heavy chain immunostaining: MF20
– red; DAPI – blue. (B) Fusion index is shown as % of nuclei contained within
myotubes to the total number of myonuclei in each microscopic field.
(C) Quantification of total myotube area is shown. Error bars show SEM,
*, + – P < 0.05 (* – compared to Ctrl; + – compared to adult Ctrl), n = 3–4.
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IGFBP5 acts both via and independently of IGF signalling pathway
(Duan et al., 2010), and both negative and positive effects of IGFBP5 on
myogenic differentiation have been shown (James et al., 1996; Cobb
et al., 2004; Salih et al., 2004; Ren et al., 2008). Despite the lack of full
understanding of IGFBP5 role in myogenesis, potentially related to
different cell types and methodologies used, the role of IGFBP5 in
promoting myoblast survival independently of IGFs has been clearly
demonstrated (Cobb et al., 2004). The role of Igfbp5 in cellular
senescence has also been previously shown (Kim et al., 2007).
We propose that miR-143 exerts its function during muscle regen-
eration through regulating Igfbp5 expression by mainly affecting
myoblast viability (Figs 4 and 5) and therefore regulating the number
of myoblasts ‘available’ to differentiate. However, our data suggest that
human and mouse myoblasts overexpressing Igfbp5, even though more
viable, may not be fully functional due to their cellular senescence (Figs 5
and 6). Our data suggest that miR-143 regulates myoblasts viability by
controlling Igfbp5 expression (Figs 2 and 5). As the levels of Igfbp5
expression alone have a moderate effect on myogenesis, we propose
that the balance between miR-143 interactions with Igfbp5 as well as
Igf1r regulates myogenic differentiation. Our data clearly demonstrate
that the inhibition of miR-143 or IGFBP5 overexpression results in an
increased number of senescent cells and this is most likely regulated, to a
large degree, in a p16-dependent manner as silencing of the expression
of p16 prevented the increase in the number of senescent cells following
IGFBP5 or AM143 treatment (Fig. 6). We therefore hypothesize that
age-related decrease in miR-143 expression and concomitant upregu-
lation of its target, Igfbp5, may be a failed attempt of the cells to
compensate for age-related changes in the satellite cells as despite the
positive effect of miR-143 downregulation on cell viability, the
concomitant upregulation of IGFBP5 expression may be inducing cellular
senescence. This is keeping with previous data showing that such
compensatory mechanisms exist. For example, increased expression of
miR-206 in the muscle of ALS mouse model has been shown to
compensate the neuromuscular interactions (Williams et al., 2009).
Interestingly, increased expression of Igfbp5 and other Igfbps in the
muscle has been demonstrated in other than aging scenarios, for
example in diabetes also associated with changes in IL-6 levels
(Sreekumar et al., 2002). miR-143 expression is, however, not affected
in this model. Based on the recent data by Soares et al. (2014), we
hypothesize that microRNA-143 function, as well as Igfbp5 regulation, is
context dependent; specifically, miR-143:Igfbp5 interactions in the
satellite cells during aging are likely to be among the key interactions
regulating the balance between cell viability and senescence during
aging, whereas in other scenarios, such as diabetes or cachexia, Igfbp5
genes may be regulated by a different set of microRNAs.
Finally, we show that IL-6 controls the expression of both miR-143 and
Igfbp5 in humans and mouse myoblasts in vitro. Aging-related increase in
levels of circulatory IL-6 has been previously reported in humans andmice,
and IL-6 has been proposed as one of the factors contributing to age-
related decline in organism function (Washington et al., 2011). The role of
IL-6 in cellular senescence has also been demonstrated (Kojima et al.,
2013). It remains to be establishedwhether the effects of IL-6 onmiR-143:
Igfbp5 interactions are maintained in vivo and whether these indeed
contribute to defective muscle regeneration during aging.
In conclusion, our study demonstrated that miR-143:Igfbp5 interac-
tions play an important role in human and mouse myoblasts viability,
senescence and therefore myogenic potential effectively controlling
myogenesis in vitro and potentially muscle regeneration. We propose
Fig. 4 miR-143 negatively regulates the
differentiation of mouse and human
myoblasts. Expression of miR-143 and its
target gene, Igfbp5, was manipulated in
undifferentiated myoblasts using miR-143
mimic (miR-143), anti-miR-143 (AM143),
Igfbp5 overexpression construct (IGFBP5)
and/or siRNA against Igfbp5; myotubes
were stained for myosin heavy chain: MF20
- green; blue – DAPI; adult – 7-month-old
mice; old – 24-month-old mice; human –
adult. (A) MF20 immunostaining showing
myogenic differentiation regulation by miR-
143. (B) Quantification of fusion index is
shown. (C) Quantification of total myotube
area is shown (%). Error bars show SEM, * –
P < 0.05 (compared to control), n = 3–4.
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that the changes inmiR-143:Igfbp5 interactions in the satellite cells during
aging may act as a compensatory mechanism to improve satellite cell
function. It remains to be established whether the same mechanisms are
maintained in vivo. Whether these changes, when induced at the correct
time during lifespan, may override the effects of environmental changes,
such as elevated levels of circulating IL-6, and correct the regenerative
potential of satellite cells in vivo also remains to be shown through a better
understanding of mechanisms underlying age-related defective muscle
regeneration; we are opening novel opportunities for more efficient
interventions aiming at improved muscle function with age.
Experimental procedures
For the primers and reagents use, please refer to Tables S1 and S2.
Mice
The study was performed using male wild-type C57Bl/6 mice (adult:
6 months old; old – 24 months old). Mice were obtained from Charles
River (Margate). All mice were maintained under specific-pathogen free
conditions and fed ad libitum a standard chow and maintained under
barrier on a 12-h light/dark cycle. For muscle regeneration, the right
tibialis anterior muscle was injured by intramuscular injection of barium
chloride (1.2% in saline). For tissue collection, mice were culled by
cervical dislocation. The tissues were immediately excised, frozen and
stored at 80 °C. Experiments were performed in accordance with UK
Home Office guidelines under the UK Animals (Scientific Procedures) Act
1986 and received ethical approval from the University of Liverpool
Animal Welfare and Ethical Review Body (AWERB). For each experiment,
n = 3-6 biological replicates were used, each biological replicate from
n = 1 to 2 mice.
Isolation of primary myoblasts from human skeletal muscle
Experiments were approved by the University of Liverpool, University
Hospital Aintree Hospital and Wales Research Ethical Committee 6 and
were performed according to good practice guidance. Human skeletal
muscle samples (extensor digitorum brevis, tibialis anterior or abductor
halluces) derived from foot surgeries of four female patients (adult
30  2.8 years old; older 69  5 years old; BMI < 25) were pro-
vided from University Hospital Aintree, Liverpool (UK). Tissue was
digested with 1.5 U mL1 collagenase D, 2.4 U mL1 dispase II and
Fig. 5 miR-143 and IGFBP5 affect myoblast viability. Myoblasts isolated from the adult and old mice or adult human muscle were transfected with miR-143 mimic, inhibitor
(AM143), IGFBP5 overexpression construct and/or siRNA against Igfbp5 and cultured in low serum media. (A) Cell viability was established via live/dead staining (green – live
cells, yellow/red – cells undergoing apoptosis/necrosis); red circles indicate cells undergoing apoptosis/necrosis. Representative images are shown. (B) The total number of live
cells was established by MTS assay. (C) Quantification of % of dead cells is shown. Adult, old – mouse myoblasts; human – adult. Error bars show SEM, * – P < 0.05
(compared to control), n = 3–4.
miRs in muscle regeneration during aging, A. Soriano-Arroquia et al.366
ª 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
2.5 mM CaCl2. Digested muscle was plated on surfaces covered with
10 lg mL1 laminin and incubated with F-12K media complemented
with 20% FBS, 10% horse serum, 2.5 ng/ml FGF-basic (Recombinant
Human FGF-basic. Peprotech; Ref.: 100-18B), 1% L-glutamine and 1%
penicillin/streptomycin at 37 °C and 5% CO2. Primary myoblasts were
grown in DMEM supplemented with 20% FBS, 10% horse serum, 1% L-
glutamine and 1% penicillin/streptomycin.
Isolation of primary myoblasts from mouse skeletal muscle
Primary myoblasts from the adult (7 months old) and old (24 months
old) mice were prepared from EDL muscles following single fibre
isolation as previously described (Wang et al., 2008; Cheung et al.,
2012). These myoblasts retained the expression patterns of miRNAs.
Satellite cells isolation
Satellite cells were isolated using FACS as previously described (Yi & Rossi,
2011). Briefly, skeletal muscle isolated from the hind limbs of two male
mice per sorting was treated with 1.5 U mL1 collagenase D, 2.4 U mL1
dispase II and 2.5 mM CaCl2. Satellite cells were sorted as a-7 integrin+,
Sca-1, CD45, CD31. Doublets and haematopoietic and endothelial
cells (CD45+ and CD31+) were excluded from the sorting gates. A pure
population of satellite cells negative for Sca1 and highly positive for a-7
integrin was isolated (CD45, CD31, Sca1, a-7 integrin+). Anti-a7-
integrin was a gift from Dr. Aldorada Pisconti, University of Liverpool.
In vitro regeneration model
In vitro regeneration protocol, where the satellite cells located on
isolated myofibres become activated, proliferate, migrate and differen-
tiate, was used to study miR-143:Igfbp5 interactions (Bischoff, 1986;
Pasut et al., 2013). Single fibres from EDL muscle from the mice were
isolated using collagenase I (Pasut et al., 2013) and plated in matrigel-
covered wells (12-well dishes). The cultures were maintained in DMEM
supplemented with 20% foetal bovine serum, 10% horse serum and
1% penicillin/streptomycin. The formation of new myotubes was
assessed 10 days following myofibre isolation.
Fig. 6 Changes in miR-143:IGFBP5 interactions are associated with myoblast senescence and affected by IL-6 levels. (A) Myoblasts isolated from the adult and old mice or
human muscle were transfected with miR-143 mimic, inhibitor (AM143) or IGFBP5 overexpression construct; cell senescence was established via SA-b-galactosidase staining
(dark blue). Quantification of SA-b-galactosidase staining is shown as % of senescent cells. (B) Quantification of Western blots is shown (n = 3). (C) Representative Western
blot showing the expression of p16 and phosphorylation of Ser608 of RB protein in the myoblast following transfections with miR-143, AM143, IGFBP5 overexpression
construct or siRNA and/or siRNA against p16; adult, old – mouse myoblasts; human – human myoblasts. (D) Primary myoblasts were treated with 0.1 ng mL1 IL-6. qPCR
showing decreased expression of miR-143 and increased expression of its targets gene, Igfbp5, following IL-6 treatment. (E) A schematic representation of the role of
miR-143:Igfbp5 interaction in the satellite cells during aging. Expression relative to Rnu-6 (miR-143) or b-2-microglobulin (Igfbp5) is shown. Error bars show SEM,
* – P < 0.05 (Student’s t-test), n = 3–4.
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Cell culture
Primary myoblasts were cultured as described above. To induce myogenic
differentiation, 90% confluent cells were cultured in DMEM supple-
mented with 5% horse serum and 1% penicillin/streptomycin (DM).
Myoblast differentiation was assessed 5 days following the switch to DM
by immunostaining for myosin heavy chain (Goljanek-Whysall et al.,
2012a). To study proliferation and viability, cells were switched to DM
once 50% confluent. IL-6 treatment was performed for 5 days using
0.2 ng mL1 concentration of mouse or human IL-6. Images were
analysed using IMAGEJ, LOCI, UNIVERSITY OF WISCONSIN, MADISON, USA. For
morphological analysis, measurement of myotube area was assessed as
described (Goljanek-Whysall et al., 2012a).
Transfections
Myoblasts were transfected with 100 nM miRNA-143-3p or anti-miR or
1 lg Igfbp5 overexpression vector that did not contain 30UTR (Addgene,
deposited by Johnson lab, University of California, San Francisco, CA,
USA, Washington University), using Lipofectamine 2000TM, Life Technol-
ogies, Paisley, UK (Goljanek-Whysall et al., 2012a). Mock-transfected
cells served as controls unless otherwise stated. Transfection efficiency
was 40–70%, depending on the molecule transfected (Goljanek-Whysall
et al., 2012a).
Real-Time PCR and Western blotting
RNA isolation and quantitative real-time PCR were performed using
standard methods (Goljanek-Whysall et al., 2014). cDNA synthesis
(mRNA) was performed using 500 ng RNA and SuperScript II, and cDNA
synthesis (microRNA) was performed using 100 ng RNA and miRscript RT
kit II according to the manufacturer’s protocol. qPCR analysis was
performed using miRScript SybrGreen Mastermix or sso-Advanced
SybrGreen Mastermix in a 20-lL reaction mixture. Expression relative
to b-2 microglobulin and/or 18S (mRNA) or Rnu-6 and/or Snord-61
(microRNA) was calculated using delta delta Ct method. Data distribution
was assessed using Mann–Whitney U test, and P-value was calculated
using unpaired two-tailed Student’s t-test. Protein lysis and Western
blots were performed as described (Goljanek-Whysall et al., 2014).
In vitro miRNA target validation
miR-143-3p targets were predicted using TargetScan v.6.2. 30UTR
regions with wild-type or mutated miR-143 target site, were synthesized
using GeneArt service (Invitrogen, Paisley, United Kingdom) and cloned
into a GFP TOPO vector (Invitrogen). Mouse myoblasts were cultured in
6-well plates and transfected using Lipofectamine 2000TM with WT or
mutant sensor (1000 ng), with or without miR-143 or miR-24 mimic
(50 nM) (Goljanek-Whysall et al., 2012a). Transfection with empty GFP
vector was used as a negative control. Each experiment was carried out
39 using independent plasmid preparations. Protein was extracted after
48 h, and GFP expression was analysed by Western blotting.
MTS assay and live/dead staining of human and mouse
myoblasts
Myoblast proliferation was assessed by Ki67 staining and MTS assay
(Zhang et al., 2012). Briefly, cells were transfected as indicated and the
proportion of Ki67-+ cells was assessed 48 h later (Goljanek-Whysall
et al., 2012a). Myoblast death was established by live/dead staining.
Briefly, cells were washed in PBS and stained with acridine orange/
ethidium bromide: PBS (1:1000); images were taken 5–60 min following
the staining.
Staining of primary myoblasts culture to determine
senescence
Senescence staining of primary myoblasts was performed 7 days after
transfections using Senescence b-Galactosidase Staining Kit (9860; Cell
Signalling Technology 3 Trask Lane, Danvers, MA 01923) according to
the manufacturer’s protocol. Pictures were captured with Zeiss Axiovert
200M Research Inverted Microscope at 109 magnification power.
Senescence staining was quantified as described in Acosta et al. (2008).
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